American Association for Cancer Research
MRI may be noninvasive method to measure breast cancer prognosis
Quantitative magnetic resonance imaging measures were associated with prognostic tumor markers, demonstrating the potential of magnetic resonance imaging for prediction of disease prognosis and stratification of patients ...
Cancer
Dec 08, 2011 |
not rated yet |
0
Obesity linked to worse outcomes in early breast cancer treatment
Obesity is associated with worse outcomes overall in early-stage breast cancer, researchers reported at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 6-10, 2011.
Cancer
Dec 08, 2011 |
not rated yet |
0
Addition of bevacizumab to conventional therapy improved progression-free survival in HER2-positive breast cancer
Data evaluated by an independent review committee revealed that the addition of bevacizumab to trastuzumab and docetaxel significantly improved progression-free survival in HER2-positive breast cancer, despite findings from ...
Cancer
Dec 08, 2011 |
not rated yet |
0
Breast cancer mortality higher in Hispanic women
Hispanic women are more likely to die from breast cancer than non-Hispanic white women, according to research presented at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 6-10, 2011.
Cancer
Dec 08, 2011 |
not rated yet |
0
Dual HER2 blockade significantly extends progression-free survival
Adding pertuzumab to a combination of trastuzumab and docetaxel chemotherapy extended progression-free survival by a median of 6.1 months in patients with metastatic HER2-positive breast cancer compared with patients who ...
Cancer
Dec 08, 2011 |
not rated yet |
0
Oral bisphosphonate did not improve prognosis for patients with breast cancer
Results from a German study demonstrated no improvement in disease-free survival among patients with breast cancer who were treated with dose-dense chemotherapy and the bisphosphonate ibandronate.
Cancer
Dec 07, 2011 |
not rated yet |
0
Clodronate appeared safe, modestly affected breast cancer disease events
A recently presented study revealed that the bisphosphonate clodronate had a low incidence of adverse events and toxicity among patients with breast cancer and may modestly reduce the incidence of distant metastases in postmenopausal ...
Cancer
Dec 07, 2011 |
not rated yet |
0
Immediate bisphosphonate use with endocrine therapy increased survival in postmenopausal early breast cancer
The addition of zoledronic acid to adjuvant endocrine therapy increased bone mineral density and reduced the risk for disease recurrence among postmenopausal women with early hormone receptor-positive breast cancer, according ...
Cancer
Dec 07, 2011 |
not rated yet |
0
Zoledronic acid shows long-term benefit in survivorship for premenopausal ER-positive breast cancer
Researchers have proven the continuing effectiveness of treating patients with estrogen receptor-positive premenopausal breast cancer with adjuvant zoledronic acid in addition to adjuvant endocrine treatment including ovarian ...
Cancer
Dec 07, 2011 |
not rated yet |
0
New test predicts risk for recurrence for patients with DCIS
In a significant advance for patients with ductal carcinoma in situ, researchers have developed and prospectively validated a multigene test to identify the risk for recurrence of breast cancer.
Cancer
Dec 07, 2011 |
not rated yet |
0
Diabetes and obesity increase risk for breast cancer development
Having diabetes or being obese after age 60 significantly increases the risk for developing breast cancer, a Swedish study has revealed. Data also showed that high blood lipids were less common in patients when diagnosed ...
Cancer
Dec 07, 2011 |
not rated yet |
1
Mammography screening reduced risk for death from breast cancer by half
A new case-control study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research, shows that women who participated in at least three screening mammograms had a ...
Cancer
Dec 06, 2011 |
not rated yet |
0
Coffee may protect against endometrial cancer
Long-term coffee consumption may be associated with a reduced risk for endometrial cancer, according to a recent study in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Ca ...
Cancer
Nov 22, 2011 |
not rated yet |
0
|
Panel of melanoma mutations opens door to new treatment possibilities
Researchers have developed a new genetic screening tool that will aid in the investigation of possible treatments for patients with melanoma and the unique genetic mutations that may accompany the disease, according to data ...
Cancer
Nov 15, 2011 |
5 / 5 (1) |
0
Some tumors contain factors that may block metastasis
Scientists are another step closer to understanding what drives tumor metastasis, as laboratory models suggest there are factors inside tumors that can slow their own growth.
Cancer
Nov 14, 2011 |
5 / 5 (1) |
0
